Recombinant CD274 (Durvalumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD274 (Durvalumab Biosimilar) products
- CD274 (Durvalumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD274 (Durvalumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Durvalumab Biosimilar Antibody
- Specificity
- B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.71 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- CD274 (Durvalumab Biosimilar)
- Alternative Name
- Durvalumab Biosimilar (CD274 (Durvalumab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
- B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
- UniProt
- Q9NZQ7
- CAS-No
- 1428935-60-7
-
You are here:
